Why paying people to get the coronavirus vaccine won't work

Millions of Americans say they won't get the vaccine. Will money change their minds? And is luring them with cash the right approach?

Robert Gatter, Professor of Law, Saint Louis University • conversation
Dec. 11, 2020 • ~10 min

Vaccines against SARS-CoV-2 will have side effects – that's a good thing

The side effects of new SARS-CoV-2 vaccines are a result of immune system activation. While uncomfortable, they are both normal and expected. They are a sign that the vaccine is working.

Matthew Woodruff, Instructor, Lowance Center for Human Immunology, Emory University • conversation
Dec. 3, 2020 • ~9 min

What are emergency use authorizations, and do they guarantee that a vaccine or drug is safe?

The vaccines that will first be used to prevent the spread of COVID-19 will have gone through a special approval process with the FDA. but just what is this expedited process?

Jeremy Greene, Professor of Medicine, Johns Hopkins University • conversation
Dec. 3, 2020 • ~10 min

COVID-19 vaccines were developed in record time – but are these game-changers safe?

Because Pfizer-BioNTech and Moderna vaccines have been developed in record time, many wonder whether companies cut corners or compromised safety.

William Petri, Professor of Medicine, University of Virginia • conversation
Nov. 20, 2020 • ~6 min

How mRNA vaccines from Pfizer and Moderna work, why they're a breakthrough and why they need to be kept so cold

There are two new COVID-19 vaccines that appear to be more than 90% effective. But what are these vaccines, and how are they different from those used previously?

Sanjay Mishra, Project Coordinator & Staff Scientist, Vanderbilt University Medical Center, Vanderbilt University • conversation
Nov. 18, 2020 • ~8 min

Why we didn't get a vaccine by Election Day – but why we may get one soon

With COVID-19 cases soaring across the US and worldwide, the need for a vaccine could not be greater. With some half-dozen vaccines in phase 3 trials, why wasn't one ready before Election Day?

William Petri, Professor of Medicine, University of Virginia • conversation
Nov. 10, 2020 • ~9 min

Video: An infectious disease expert explains the results from Moderna's latest vaccine trials

The results from the phase 1 trial are a promising first step in showing that the mRNA vaccine is a viable candidate, but there are unanswered questions and it is still early in the process.

Sanjay Mishra, Project Coordinator & Staff Scientist, Vanderbilt University Medical Center, Vanderbilt University • conversation
July 17, 2020 • ~8 min

An infectious disease expert explains the results from Moderna's latest vaccine trials

The results from the phase 1 trial are a promising first step in showing that the mRNA vaccine is a viable candidate, but there are unanswered questions and it is still early in the process.

Sanjay Mishra, Project Coordinator & Staff Scientist, Vanderbilt University Medical Center, Vanderbilt University • conversation
July 17, 2020 • ~8 min

/

3